1684年（清康熙二十三年），时任太医院吏目的乐显扬因医术高超、医德高尚，被康熙皇帝诰封为“登仕佐郎”

In 1684, the 23rd Qing Kangxi reign, Mr. Yue Xianyang, the senior physician and instruction at the Imperial Hospital, was officially conferred on him a ninth-grade official rank by Emperor Kangxi of the Qing dynasty for his excellent medical skills and professional ethics.

1702年（清康熙四十一年），乐凤鸣在北京前门外大栅栏开设同仁堂药铺

1706年（清康熙四十五年），乐凤鸣编写完成《同仁堂乐氏世代祖传丸散膏丹下料配方》（简称《同仁堂传统配本》）和《同仁堂虔修诸门应症丸散膏丹总目》（简称《同仁堂药目》），为同仁堂制作药品建立起严格的选方、用药、配比和工艺规范

In 1706, the 45th Qing Kangxi reign, Mr. Yue Fengming completed TRT Traditional Medicine Matching based on the herbal medicine recipes in the forms of pill, pulvis, emplastrum and unguentum, and pellet handed down from the founders from one generation to another, and TRT Materia Medica, which caters to various indication also in the similar forms. As a whole, these two great medical works mandate such norms for Tongrentang as strict selection of prescriptions, application, proportioning, and process.

1723年（清雍正元年），同仁堂开始为清宫供御药，历经雍正、乾隆、嘉庆、道光、咸丰、同治、光绪、宣统八代皇帝，长达188年

In 1723, the 1st Qing Yongzheng reign, Tongrentang initiated its medication supply to the Qing Imperial Palace, over the eight reigns , for 188 years.

1949年，新中国成立使同仁堂获得了新生

In 1949, the founding of the People’s Republic of China gave Tongrentang a new life.

1953年，同仁堂研制生产了中国第一批中药片剂，结束了中药只有丸、散、膏、丹传统剂型的历史，开创了先河

In 1953, Tongrentang developed the first batch of Traditional Chinese Medicine tablets, unprecedentedly ended the history of sole forms of pill, powder, ointment and pellet.

1955年，同仁堂经理乐松生在中南海受到毛泽东主席和周恩来总理的亲切接见，被选为北京市人大代表，出任北京市副市长

In 1955, Mr. Yue Songsheng, the president of Tongrentang, was cordially received by Chairman Mao Zedong and Premier Zhou Enlai at Zhongnanhai. He was elected as a deputy of the Beijing People’s Congress and the vice mayor of Beijing municipality.

1989年，“同仁堂”商标成为中国“首批马德里商标注册”的国际商标

In 1989, the “Tongrentang” trademark was among the first Chinese trademark registered in Madrid.

1992年，中国北京同仁堂（集团）公司组建成立。

In 1992, China Beijing Tong Ren Tang Group Company was incorporated.

1993年，同仁堂获得进出口经营权，在香港开设第一家门店，从此以香港为桥头堡走向世界，目前已实现了在五大洲28个国家和地区的业务布局。

In 1993, Tongrentang set up its first pharmacy in Hong Kong, as a bridgehead to other parts of the world. So far Tongrentang’s overseas business has been distributed in 28 countries and regions.

1997年，北京同仁堂股份有限公司成立，并在上交所上市，标志着同仁堂在建立现代化企业制度的进程中迈出重要步伐。

In 1997, Beijing Tong Ren Tang Co., Ltd. was established, and was also listed on the Shanghai Stock Exchange.

2000年，北京同仁堂科技发展股份有限公司成立，并在香港创业板上市，为国内首家由A 股分拆上市的企业。

In 2000, Beijing Tong Ren Tang Technology Development Co., Ltd. was formed, and was also listed on the Hong Kong Growth Enterprises Market, as the first subsidiary A-share IPO enterprise.

2001年，中国北京同仁堂（集团）有限责任公司正式揭牌，标志着同仁堂实现了规范化的公司制改革

In 2001, China Beijing Tong Ren Tang (Group) Co., Ltd. unveiled the plaque officially, which signaled its achievement of the standardized corporate system reform.

2006年，中华人民共和国商务部认定中国北京同仁堂（集团）有限责任公司为首批“中华老字号”，“同仁堂中医药文化”入选首批国家级非物质文化遗产代表性名录

In 2006, China Beijing Tong Ren Tang (Group) Co., Ltd. was assessed to be among the first batch of “China Time-honored Brand”, whereas “Tongrentang Traditional Chinese Medicine Culture” was inscribed on the representative first batch of the national intangible cultural heritages.

2013年，北京同仁堂国药有限公司在香港创业板上市，成为同仁堂集团旗下第三家上市公司

In 2013, Beijing Tong Ren Tang Chinese Medicine Co., Ltd. was listed on the Hong Kong Growth Enterprises Market, as the 3rd listed subsidiary company within Tongrentang Group.

2018年，同仁堂粹和康养天坛生活馆开业，同仁堂正式进入养老领域，并向大健康产业进军

In 2018, Tiantan Life Hall of TRT CUIHE Healthcare started its business, officially established as a pacesetter for elder-caring and greater health sector.

2019年，同仁堂公开聘请第三方权威机构开展战略咨询，标志着历经350年风雨历程的中华老字号企业，通过创新发展理念，以实际行动夯实党建基石、质量基石、诚信基石，迈上高质量发展之路

In 2019, Tongrentang invited openly a third party competent institution for strategic consultancy. This marks that China Time-honored Brand business with a history of 350 years is pursuing for development of higher quality, through the vision of innovative development and actual enhancement of Party construction and credit-standing.